Scienture Holdings, Inc.
Nasdaq · Healthcare · Pharmaceutical Preparations · Commack, NY
SCNX chart
What traders are saying about $SCNX
Latest postsScienture Holdings, Inc. news
- Maxim Group Maintains Scienture Holdings(SCNX.US) With Buy Rating, Cuts Target Price to $6
Moomoo ·
- Scienture Holdings (NASDAQ:SCNX) Penny Stock Falls in a Month on a Split and a Revenue Miss
kalkine.ca ·
- Scienture Holdings, Inc. Estimates – NASDAQ:SCNX
TradingView ·
- Scienture price target lowered to split-adjusted $6 at Maxim
TipRanks ·
- Scienture Holdings Well Positioned to Deliver Continued Sequential Rev Growth >SCNX
Moomoo ·
- Scienture reports Q3 revenue of $1.22 million, up 256% sequentially
Investing.com ·
- Scienture reports Q3 revenue of $1.22 million, up 256% sequentially By Investing.com
Investing.com UK ·
- Scienture reports 256% revenue jump in Q3 on two FDA products
StreetInsider ·
- SCIENTURE Issues Shareholder Letter Highlighting Sequential Revenue Growth, Two FDA-Approved Commercial Products, and Continued Progress Toward Profitability in 2027
Yahoo Finance ·
- Scienture Holdings Regains Nasdaq Compliance Amid Revenue Surge
The Globe and Mail ·
- SCIENTURE Reports Approximately $1.22 Million in Unaudited Preliminary Q3 2026 Revenue, Achieving 256% Sequential Growth
Yahoo Finance ·
- EXCLUSIVE: Scienture Revenue Soars 256% As Drugmaker Targets 2027 Profitability
Yahoo Finance ·
Scienture Holdings, Inc. key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | $431,609 | $136,643 | $1.4M | $10.3M |
| Net income | -$41.5M | $13.6M | -$17.8M | -$3.5M |
| Diluted EPS | $-2.70 | $2.48 | $-23.35 | $-6.13 |
| Total assets (year end) | $84.2M | $104.9M | $12.5M | $3.7M |
| Cash and equivalents (year end) | $6.7M | $308,096 | $361 | $1.1M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Scienture Holdings, Inc.
- Ticker
- SCNX (Nasdaq)
- Industry
- Pharmaceutical Preparations
- Headquarters
- Commack, NY
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 1382574
- Former names
- TRxADE HEALTH, INC, TRXADE GROUP, INC., XCELLINK INTERNATIONAL INC.
Frequently asked questions
What exchange is Scienture Holdings, Inc. listed on?
Scienture Holdings, Inc. trades on the Nasdaq under the ticker symbol SCNX.
What industry is Scienture Holdings, Inc. in?
Scienture Holdings, Inc. is classified by the SEC under "Pharmaceutical Preparations", part of the Healthcare sector on StockTweeting.
Where is Scienture Holdings, Inc. headquartered?
Scienture Holdings, Inc.'s business address on file with the SEC is in Commack, NY.
When does Scienture Holdings, Inc.'s fiscal year end?
Scienture Holdings, Inc.'s fiscal year ends on December 31.
How much revenue did Scienture Holdings, Inc. report?
Scienture Holdings, Inc. reported $431,609 in revenue for calendar year 2025, according to its SEC filings.